The firm's average rating is Buy from 5 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Acutus Medical market sentiment investors' perception of the future value of Acutus. Let us look at a few aspects of Acutus technical analysis.
Using predictive
technical analysis, we can analyze different prices and returns patterns and
diagnose historical swings to determine the real value of Acutus Medical. In general, sophisticated investors focus on analyzing Acutus Medical stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build Acutus Medical's daily price indicators and compare them against related drivers such as
momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional
technical analysis and
fundamental analysis, we attempt to find the most accurate representation of
Acutus Medical's intrinsic value. In addition to deriving basic predictive indicators for Acutus Medical, many experienced traders also check how macroeconomic factors affect Acutus Medical price patterns. Please read more on our
technical analysis page or use our predictive modules below to complement your research.
Watch out for price decline
Please consider monitoring Acutus Medical on a daily basis if you are holding a position in it. Acutus Medical is trading at a penny-stock level, and the possibility of delisting is much higher compared to other delisted stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Acutus Medical stock to be traded above the $1 level to remain listed. If Acutus Medical stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How does Acutus Stands against Peers?
Analyzing Acutus Medical competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Acutus Medical across multiple sectors and
thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be. Check out
Acutus Medical Competition DetailsCloser look at Acutus Medical Semi Variance
Acutus Medical has current Semi Variance of 14.24. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.
Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Semi Variance | = | SUM(RET DEV)2 N(ZERO) |
| = | 14.24 |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
Let's now compare Acutus Medical Semi Variance to its closest peers:
| AFIB | 14.243369978968868 |
| ESMC | 88.9 |
| ESTA | 11.3 |
| EW | 3.59 |
| ECTE | 96.43 |
Acutus Medical has 81 percent chance to slip way below $34 in October
The potential upside is down to 8.84 as of today. Acutus Medical shows above-average downside volatility for the selected time horizon. We advise investors to inspect Acutus Medical further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Acutus Medical future alpha.
The Current Takeaway on Acutus Medical Investment
Whereas other companies under the medical devices industry are still a bit expensive, Acutus Medical may offer a potential longer-term growth to investors. To summarize, as of the 16th of September 2020, we believe that Acutus Medical is currently
fairly valued with
low chance of distress in the next two years. Our actual 30 days buy-sell recommendation on the company is
Strong Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of Acutus Medical. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]